Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free EGRX Stock Alerts $4.77 +0.22 (+4.84%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Eagle Pharmaceuticals Stock Price Performance5 Day Performance+3.47%1 Month Performance-5.54%3 Month Performance-3.44%6 Month Performance-65.95%Year-To-Date Performance-8.80%1 Year Performance-82.78% Receive EGRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him EGRX Stock Chart for Wednesday, April, 24, 2024 EGRX Chart by TradingView Eagle Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$4.55$4.77+4.84%$5.01$4.5588,216 shs$61.96 million04/22/2024$4.61$4.55-1.30%$4.81$4.51283,208 shs$59.10 million04/19/2024$4.48$4.61+2.90%$4.74$4.4859,516 shs$59.88 million04/18/2024$4.39$4.48+2.05%$4.75$4.36135,741 shs$58.20 million04/17/2024$4.69$4.39-6.40%$4.77$4.37109,204 shs$57.03 million04/16/2024$5.20$4.69-9.81%$5.20$4.57161,336 shs$60.92 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$4.59$5.20+13.29%$5.26$4.28379,131 shs$67.55 million04/12/2024$4.77$4.59-3.77%$4.81$4.57127,108 shs$59.62 million04/11/2024$4.70$4.77+1.49%$4.81$4.56102,479 shs$61.95 million04/10/2024$4.95$4.70-5.05%$4.88$4.60114,324 shs$61.04 million04/09/2024$5.00$4.95-1.00%$5.05$4.8778,526 shs$64.30 million04/08/2024$5.12$5.00-2.34%$5.26$4.8490,425 shs$64.95 million04/05/2024$5.21$5.12-1.73%$5.20$4.99144,722 shs$66.51 million04/04/2024$4.86$5.21+7.20%$5.27$4.9298,162 shs$67.68 million04/03/2024$4.50$4.86+8.00%$4.95$4.41689,091 shs$63.13 million04/02/2024$4.77$4.50-5.66%$4.77$4.46133,182 shs$58.46 million04/01/2024$5.24$4.77-8.97%$5.25$4.73173,849 shs$61.96 million03/29/2024$5.24$5.24$5.37$4.9680,453 shs$68.07 million03/28/2024$5.01$5.24+4.59%$5.37$4.9680,452 shs$68.07 million03/27/2024$5.04$5.01-0.60%$5.12$4.91100,867 shs$65.08 million03/26/2024$5.08$5.04-0.79%$5.19$5.0251,509 shs$65.47 million03/25/2024$5.05$5.08+0.59%$5.23$4.93129,342 shs$65.97 million03/22/2024$5.23$5.05-3.44%$5.25$4.90159,415 shs$65.60 million03/21/2024$5.68$5.23-7.92%$5.82$5.23105,056 shs$67.94 million03/20/2024$5.50$5.68+3.27%$5.77$5.3999,517 shs$73.78 million03/19/2024$5.62$5.50-2.14%$5.68$5.20183,202 shs$71.45 million03/18/2024$6.05$5.62-7.11%$6.19$5.54144,807 shs$73.00 million03/15/2024$5.95$6.05+1.68%$6.13$5.72333,544 shs$78.59 million03/14/2024$6.01$5.95-1.00%$6.09$5.78102,500 shs$77.29 million03/13/2024$5.73$6.01+4.89%$6.16$5.7878,657 shs$78.07 million03/12/2024$5.87$5.73-2.39%$5.94$5.58153,534 shs$74.43 million03/11/2024$6.25$5.87-6.08%$6.20$5.74124,565 shs$76.23 million03/08/2024$6.25$6.25$6.50$6.2473,784 shs$81.19 million03/07/2024$6.35$6.25-1.57%$6.40$6.0688,434 shs$81.19 million03/06/2024$6.51$6.35-2.46%$6.74$6.2464,369 shs$82.49 million03/05/2024$6.29$6.51+3.50%$6.65$6.31117,107 shs$84.57 million03/04/2024$6.48$6.29-2.93%$6.70$6.13128,450 shs$81.71 million03/01/2024$5.86$6.48+10.58%$6.81$5.89188,269 shs$84.18 million02/29/2024$6.27$5.86-6.54%$6.44$5.73154,847 shs$76.12 million02/28/2024$6.44$6.27-2.64%$6.45$6.1699,589 shs$81.45 millionThousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage"02/27/2024$6.48$6.44-0.62%$6.65$6.23113,274 shs$83.66 million02/26/2024$6.25$6.48+3.68%$6.54$6.16134,242 shs$84.16 million02/23/2024$5.87$6.25+6.47%$6.32$5.75166,785 shs$81.19 million02/22/2024$6.23$5.87-5.78%$6.24$5.87120,273 shs$76.25 million02/21/2024$5.99$6.23+4.01%$6.43$5.93125,367 shs$80.93 million02/20/2024$5.97$5.99+0.34%$6.09$5.80256,844 shs$77.81 million02/19/2024$5.97$5.97$6.13$5.80157,300 shs$77.55 million02/16/2024$5.85$5.97+2.05%$6.13$5.80156,530 shs$77.53 million02/15/2024$5.25$5.85+11.43%$5.85$5.21207,072 shs$75.99 million02/14/2024$5.21$5.25+0.77%$5.39$5.18143,790 shs$68.20 million02/13/2024$5.60$5.21-6.96%$5.54$5.05405,157 shs$67.68 million02/12/2024$5.32$5.60+5.26%$5.82$5.30351,684 shs$72.74 million02/09/2024$5.32$5.32$5.46$5.18247,551 shs$69.11 million02/08/2024$5.17$5.32+3.00%$5.34$5.02195,482 shs$69.11 million02/07/2024$4.90$5.17+5.41%$5.32$4.67321,338 shs$67.09 million02/06/2024$5.60$4.90-12.50%$5.64$4.59689,652 shs$63.65 million02/05/2024$5.85$5.60-4.27%$5.77$5.41214,433 shs$72.74 million02/02/2024$6.08$5.85-3.78%$6.07$5.59271,122 shs$75.97 million02/01/2024$5.86$6.08+3.75%$6.14$5.81352,184 shs$78.98 million01/31/2024$5.48$5.86+6.93%$5.90$5.45354,497 shs$76.12 million01/30/2024$5.51$5.48-0.54%$5.63$5.33165,716 shs$71.19 million01/29/2024$5.41$5.51+1.85%$5.54$5.08216,600 shs$71.58 million01/26/2024$5.30$5.41+2.08%$5.45$5.25138,113 shs$70.28 million01/25/2024$4.94$5.30+7.29%$5.33$4.94313,964 shs$68.85 million01/24/2024$4.73$4.94+4.44%$4.95$4.64583,416 shs$64.17 million01/23/2024$4.42$4.73+7.01%$4.80$4.41710,152 shs$61.44 million Related Companies: HCWB Stock Price Chart CKPT Stock Price Chart VHAQ Stock Price Chart GMTX Stock Price Chart LTRN Stock Price Chart KZR Stock Price Chart EQ Stock Price Chart KRON Stock Price Chart MRNS Stock Price Chart VAXX Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.